Aminoglycosides in Critically Ill Septic Patients With Acute Kidney Injury Receiving Intermittent Hemodialysis: A Multicenter, Observational Study

Alexandre Boyer (1) , Jean-François Timsit (2) , Kada Klouche (3, 4) , Emmanuel Canet (5) , Thuy-Nga Phan (6) , Julien Bohé (6) , Sebastien Rubin (1) , Arthur Orieux (1) , Alexandre Lautrette (7) , Didier Gruson (1) , Bertrand Souweine (7)

1 CHU Bordeaux
2 CHUGA - Centre Hospitalier Universitaire [CHU Grenoble]
3 PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046]
4 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
5 AP-HP - Hopital Saint-Louis [AP-HP]
6 CHLS - Centre Hospitalier Lyon Sud [CHU - HCL]
7 CHU Gabriel Montpied [Clermont-Ferrand]

Domaines: Sciences du Vivant [q-bio]

Alexandre Boyer, Jean-François Timsit, Kada Klouche, Emmanuel Canet, Thuy-Nga Phan, et al.. Aminoglycosides in Critically Ill Septic Patients With Acute Kidney Injury Receiving Intermittent Hemodialysis: A Multicenter, Observational Study. Clinical Therapeutics, 2021, ⟨10.1016/j.clinthera.2021.04.015⟩. ⟨hal-03258710⟩